FEVI 49 4 (5-8)% predicted with allergic bronchopulmonary aspergillosis (all with current or previous positive precipitins to A fumigatus) and in 11 asthmatic patients of mean (SE) age 495 (5-8) years, FEVI 75.5 (6 5 ) % predicted, skin test positive for A fumigatus, but without the clinical or serological features of allergic bronchopulmonary aspergillosis (nonallergic bronchopulmonary aspergillosis group). Results -Bronchial dilatation was more common in the group with allergic bronchopulmonary aspergillosis, affecting 14 patients compared with two in the nonallergic bronchopulmonary aspergillosis group. Evidence of bronchiectasis was found in 43 of a possible 102 lobes of patients with allergic bronchopulmonary aspergillosis, compared with three of a possible 66 in the non-allergic bronchopulmonary aspergillosis group. Bronchial wall thickening was common to both, affecting 16 and nine patients respectively. Pleural thickening on CT scanning was common in the group with allergic bronchopulmonary aspergillosis, being noted in 14 patients compared with only three in the non-allergic bronchopulmonary aspergillosis group. Allergic bronchopulmonary aspergillosis is a disease of asthmatic patients characterised by a potent humoral immune response to Aspergillusfumigatus. It may follow a protracted course and may progress to result in chronic lung damage such as central bronchiectasis or pulmonary fibrosis. ' Until recently it has been generally accepted that central bronchiectasis was virtually pathognomonic for the diagnosis of allergic bronchopulmonary aspergillosis and not a feature of uncomplicated asthma. This view has been challenged by Neeld et al4 who found evidence of bronchiectasis in 41 % of lobes in a group of patients with allergic bronchopulmonary aspergillosis, and in 15% of lobes in asthmatic patients with a positive skin test for A fumigatus but without other features of allergic bronchopulmonary aspergillosis. Paganin et al5 also found some degree of bronchiectasis on computed tomographic (CT) scanning in 56% of asthma patients with no evidence of Aspergillus allergy. Clearly, if this were the case it would have implications for the treatment and evaluation of therapies in chronic asthma.
Conclusions
Narrow section CT scanning is the investigation of choice in the diagnosis of bronchiectasis. It is superior to plain chest radiography in detecting bronchiectasis46 and, in comparison with bronchography which is considered unsafe in asthma,7 has a sensitivity in some series approaching 95% and a specificity of around 90%. 8 A Philips Tomoscan 310 with a 9 5 second scan time was used. Thin section studies were performed using a 3 mm slice thickness scanning at 9 mm increments and the images were reconstructed using a high spatial frequency algorithm. The CT images were analysed separately by two senior radiologists in a blinded fashion, differences being resolved by consensus.
Bronchiectasis was deemed to be present if the bronchial diameter was greater than that of the accompanying artery9 10 and was defined as being central when confined to the medial two thirds of the lung. The degree of bronchiectasis was also assessed, being allocated to one of three categories: mild -where the bronchial diameter was only slightly larger than the accompanying artery; marked -where the dilatation was obvious; and cystic -where the bronchi showed cystic dilatation.
Bronchial wall thickening was evaluated by comparison with areas of normal lung in any individual.910 Other features including pleural thickening, parenchymal shadowing, volume loss, and emphysematous changes were also noted.
Each lobe in every patient was analysed separately. CHEST 
RADIOGRAPHS
Posteroanterior chest radiographs were also performed at the time of scanning. These were (table 3) . Parenchymal shadowing and emphysematous changes were more common in the group with allergic bronchopulmonary aspergillosis than in those without the condition (table 3) .
Discussion
Our findings indicate several important differences between the two groups studied. Bronchiectasis was a common feature of the group with allergic bronchopulmonary aspergillosis, affecting most patients and a large percentage of lobes. As with previous descriptions in allergic bronchopulmonary aspergillosis, the bronchiectasis noted was mainly situated centrally. In contrast, bronchiectasis was uncommon in patients without allergic bronchopulmonary aspergillosis. Signs of bronchiectasis were noted in only 12 of the 16 affected patients on the plain chest radiographs performed at the same time as the CT scans, re-emphasising the greater sensitivity of CT 6 9 scanning.
In the patients with allergic bronchopulmonary aspergillosis bronchial dilatation was found in similar numbers of patients and lobes as was reported in the studies by Neeld et al and Currie et al.46 In contrast, bronchiectasis was found in only 5% of lobes of patients without allergic bronchopulmonary aspergillosis, whereas Neeld reported this in 15% of lobes in a similarly defined group.4 There may be some differences between their patients and those of the present study as the three patients with bronchiectasis in their group of eight non-allergic bronchopulmonary aspergillosis patients were taking oral corticosteroids, suggesting that they had more severe asthma; neither of our two non-allergic bronchopulmonary aspergillosis patients with bronchiectasis were taking oral corticosteroids. Our findings are in even more marked contrast to the findings of Paganin et a15 who recently reported that there was evidence of bronchiectasis on CT scanning in 56% of asthmatic patients across a varying severity of disease. The patients in their study were different in that none were smokers and none had evidence of hypersensitivity to A fumigatus. Similarly, some of their patients were scanned when acutely unwell which may exaggerate the incidence of bronchiectasis if acute transient dilatation occurred which resolved with treatment. Nevertheless, our findings would not corroborate their frequent finding of bronchiectasis in asthmatic patients. We also think it is unlikely that technical differences would account for this disparity although different section thicknesses and increments were used; Neeld used 1 mm sections at 15 mm intervals and Paganin used 1-5 mm sections at 10 or 20 mm intervals, compared with 3 mm sections at 9 mm intervals used in our study. Likewise, although there is a degree of subjectivity in the interpretation of scans, it seems unlikely that this would account for the differences reported as the same criteria for bronchial dilatation were used.
Pleural thickening was common in the patients with allergic bronchopulmonary aspergillosis but infrequent in those without the disease. Pleuritic chest pain has been described in allergic bronchopulmonary aspergillosis'1 although, to our knowledge, pleural thickening has not been reported. The finding of pleural thickening presumably reflects changes following episodic pleural inflammation; it should be noted, however, that this was relatively minor and unlikely to be of clinical significance. Bronchial wall thickening was common to both groups as has previously been described45 and highlights the inflammatory nature of asthma. Emphysematous changes were more common in the patients with allergic bronchopulmonary aspergillosis which is in keeping with the more severe degree of airflow obstruction noted in this group.
We conclude from our findings that bronchiectasis is common in allergic bronchopulmonary aspergillosis but occurs only occasionally in asthmatic patients with a positive skin test to A fumigatus. We would contend, therefore, that the presence of bronchiectasis should continue to be regarded as a diagnostic feature suggestive of allergic bronchopulmonary aspergillosis and should not be accepted simply as a common feature of asthma. In the evaluation of patients CT scanning is therefore useful if allergic bronchopulmonary aspergillosis is considered as a possible diagnosis. This study was supported by a grant from the Chest, Heart and Stroke Association (Scotland).
